Safety and efficacy of filgotinib for Japanese patients with RA and inadequate response to MTX: FINCH 1 52-week results and FINCH 4 48-week results.
Tanaka Y, Matsubara T, Atsumi T, Amano K, Ishiguro N, Sugiyama E, Yamaoka K, Combe BG, Kivitz AJ, Bae SC, Keystone EC, Nash P, Genovese M, Matzkies F, Bartok B, Pechonkina A, Kondo A, Ye L, Gong Q, Tasset C, Takeuchi T.
Tanaka Y, et al. Among authors: tasset c.
Mod Rheumatol. 2023 Jul 4;33(4):668-679. doi: 10.1093/mr/roac084.
Mod Rheumatol. 2023.
PMID: 35920102
Clinical Trial.